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Aim
The aim of this study was to analyse the occurrence, timing and 
predictive factors of first and subsequent local (LR), regional (RR) or 
distant (DM) recurrence during the first 10 years after treatment for 
primary invasive breast cancer in women. 
Methods
Patients were selected from the Netherlands Cancer Registry 
(N=9,342)
•	  Women diagnosed in 2003 
•	 Stage I-III invasive breast cancer without metastasis at diagnosis 
•	 Treated with curative intent 
•	 No previous or synchronous tumours 
Recurrences <3 months after diagnosis of the primary tumour 
were considered synchronous with the primary tumour. Therefore, 
follow-up time started three months after diagnosis of the primary 
tumour.  In patients with concurrent recurrences, the most serious 
site of recurrence was taken as endpoint.
Multivariable Cox proportional hazards regression was used to 
model the hazard of recurrence over time for site-specific first 
recurrence and for subsequent recurrences after LR or RR. Missing 
values were multiple imputed using a chained equation approach.
Results
After previous first LR or RR and second LR or RR, a third 
subsequent recurrence occurred in 18 patients (54.5%).
The risk of first recurrence was highest around 2 years post-
diagnosis (HR 0.040 95%CI 0.035-0.043) with a similar pattern for 
LR, RR and DM. 
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Table: Incidence of consecutive events according to recurrence site
First recurrence 
(n=9,342)
Subsequent 
recurrence 
after LR (n=362)
Subsequent 
recurrence 
after RR (n=148)
n % n % n %
Local (LR) 362 3.9 10 2.8 8 5.4
Regional (RR) 148 1.6 12 3.3 3 2.0
Distant (DM) 1343 14.4 80 22.0 63 42.6
Total 1853 19.8 102 28.2 74 50.0
Median time 
to recurrence
3.3 years 
(IQR 1.6-5.8)
1.1 years 
(IQR 0.3-2.5)
1.1 years 
(IQR 0.6-2.2)
LR = local recurrence, RR = regional recurrence, DM = distant recurrence, 
n=number; IQR = interquartile range.
In multivariable analysis, only hormone status was a significant 
predictive factor for a second recurrence after RR (HR 0.55 95%CI 
0.31-0.98). For a second recurrence after LR both hormone status 
(HR 0.56 95%CI 0.35-0.88) and 1-3 positive nodes compared to 
no positive nodes (HR 2.03 95%CI 1.29-3.18) were of significant 
influence. No significant predictors could be identified for a third 
recurrence after a LR or RR.
For both recurrences after a first LR, as well as recurrences after a 
first RR, the hazard of a subsequent second recurrence was highest 
around one year after the first recurrence.
Conclusions
The pattern of first recurrence was similar for LR, RR and DM. To 
get towards personalized follow-up, predictive factors could be 
taken into account. Besides hormone status for second recurrence 
after a RR and both hormone status and nodal involvement for 
second recurrence after a first LR, no other predictive factors were 
of significant influence. 
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